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Abstract
The critical care involved in solid-organ transplantation (SOT) is complex. Pre-, intra- and post-transplant care can 
significantly impact both – patients’ ability to undergo SOT and their peri-operative morbidity and mortality. Much 
of the care necessary for medical optimization of end-stage organ failure (ESOF) patients to qualify and then success-
fully undergo SOT, and the management of peri-operative and/or long-term complications thereafter occurs in an in-
tensive care unit (ICU) setting. The current literature specific to critical care in abdominal SOT patients was reviewed. 
This paper provides a contemporary perspective on the potential multifactorial advantages of sub-specialized trans-
plant critical care units in providing efficient, comprehensive, and collaborative multidisciplinary care.
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 Introduction
Knowledge and technology have transformed the prac-
tice of medicine, and both with the need to optimize 
outcomes have been the driving force in creating sub-
specialties in virtually every realm of clinical medi-
cine. Critical care medicine is no exception with the 
consequent evolution of sub-specialized units in the 
areas of pediatrics and neonatology, cardiology and 
cardiac surgery, and neurology and neurosurgery [1]. 
Patients with end-stage organ failure (ESOF), particu-
larly those in need of, or those who have undergone 
solid-organ transplantation (SOT), represent a unique 
patient population. Complexities in the management 
of SOT patients pose challenges to the healthcare team 
at every level. The critical care of SOT patients, both 
in the pre- and post-transplant phase, is essential. It 
impacts on their potential candidacy for donated or-
gans and subsequently influences their post-transplant 
morbidity, mortality, and allograft survival [2]. With 
pre-transplant ESOF, an extensive, complicated surgi-
cal procedure, unique post-operative management of 
the recipient (allograft included) and careful balance of 
immunosuppression, it is imperative that critical care 
rendered to the transplant patient has a multidiscipli-
nary approach inclusive of transplant physicians and 
skilled intensivists.  
 Challenges in Transplant Patients
Patients with impending or established single- or mul-
ti-organ failure can be defined as critically ill. Patients 
awaiting SOT and transplant recipients often drasti-
cally decompensate when complications arise. Review 
articles by Findlay et al. and Razonable et al. outline 
topics in critical care management of unique complica-
tions, encountered to varying degrees, in SOT patients 
[3,4]. 
 Pre-Transplant Phase
Successful management of patients with ESOF requires 
an understanding of their pathophysiology and the 
complications that may ensue. It is not uncommon to 
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encounter bouts of hepatic encephalopathy (HE) and 
spontaneous bacterial peritonitis (SBP) in potential 
liver recipients, or catheter-related multi-drug resistant 
(MDR) sepsis with disseminated infection in patients 
with end-stage renal disease (ESRD) with challeng-
ing dialysis access or those with intestinal failure de-
pendent on parenteral nutrition. Complications such 
as porto-pulmonary hypertension (PPH) and hepato-
pulmonary syndrome (HPS) in end-stage liver disease 
(ESLD) patients compromise cardiovascular physiol-
ogy, ventricular function and respiratory mechanics 
which may threaten transplantation [5]. Renal failure, 
acute or chronic, in ESLD patients necessitates early 
recognition, differentiation from hepatorenal syn-
drome (HRS), and timely treatment that may involve 
renal replacement therapy (RRT). In wait-listed ESLD 
patients, progressive deterioration of renal function or 
prolonged RRT demands periodic re-evaluation for 
multi-organ transplantation. While complications, as 
mentioned above, dictate patients’ survival, they pose 
a constant threat to their transplant eligibility and may 
jeopardize their candidacy for life-saving organ offers. 
Thus, it is essential that one understands the pursuit of 
aggressive therapy in these patients to enable them to 
receive SOT and thereby heal.
In addition to treating complications, pre-transplant 
medical optimization of ESOF patients is a vital task. 
A concerted, multidisciplinary approach is key to 
maintaining a patient’s eligibility for transplantation. 
For example, orchestrating collaborative therapeutic 
strategies with neurocritical care intensivists and neph-
rologists with regards to volume status, and hepatolo-
gists and infectious disease (ID) specialists, is critical 
for preventing a fatal outcome from elevated intracra-
nial pressure (ICP) in patients with acute liver failure 
(ALF) [6,7]. Similarly, patients suffering from PPH and 
HPS require dedicated pharmacological therapy with 
the keen management of fluid-volume status in accord 
with a pulmonologist.
 Post-Transplant Phase
Cardiovascular disease and related events are the lead-
ing cause of morbidity, graft loss, and mortality in 
kidney transplant recipients [8]. Optimizing recipi-
ent physiology following SOT yields the most signifi-
cant chance of allograft function and overall survival. 
A multivariable balancing act inclusive of continuous 
fluid-volume status adjustments, customized antico-
agulation if and when necessary, and maintenance of 
adequate tissue perfusion is vital in the restoration of 
physiological homeostasis and prevention of allograft 
thrombosis. At the time of obtaining consent before 
transplantation, patients are informed of the “big oper-
ation, big incision, big pain, big recovery, and possible 
big complications.” More often than expected, trans-
plant recipients encounter various acute or chronic 
complications.
A multitude of different bacterial, viral and fungal 
infections may plague transplant recipients requiring 
aggressive testing methods and alternative therapeutic 
strategies. Immediately post-transplant, recipients may 
suffer from wound infection, C. difficile colitis, urinary 
tract infection (UTI), or ventilator-associated events 
(VAEs) from prolonged mechanical ventilation. Bile 
leak(s) or anastomotic ductal stenosis may progress 
to cholangitis, bacteremia, sepsis and shock in liver 
recipients. Alike, urinoma(s) and ureteral stricture(s) 
may develop infectious complications in kidney recipi-
ents. Furthermore, a variety of opportunistic and late 
post-transplant infections may cause transplant recipi-
ents to be admitted to the intensive care unit (ICU). 
Frequently, transplant recipients (including kidney) 
sustain acute kidney injury (AKI) and may even re-
quire RRT. This may exacerbate cardiorespiratory in-
sufficiency or failure especially in recipients with pre-
existing pulmonary complications of cirrhosis or those 
with suboptimal cardiac or ventricular function. That 
said, very often we witness liver transplantation to be 
the therapy, cause for the cure of HRS, HPS, PPH, cer-
ebral edema, hyperdynamic circulation, multifactorial 
coagulopathy, and Kwashiorkor malnutrition [9]. Such 
remarkable transformations are mainly limited to the 
field of SOT.
The incidence and severity of post-transplant com-
plications are remarkably high in intestinal transplant 
(IT) recipients. In this group of SOT recipients — mi-
cronutrient deficiencies commonly occur due to the 
gradual allograft adaptation. Acute and/or chronic al-
lograft rejection may manifest with increased stomal 
output and consequent AKI, and sepsis secondary to 
bacterial translocation [10,11]; and graft-versus-host 
disease (GVHD) has an incidence of 7% due to the 
presence of a robust intestinal lymphatic system which 
may present with hepatic dysfunction and bone mar-
row depression [12].
A widening gap between the supply of allografts 
appropriate for transplantation and the continu-
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ous increase in demand concerning patients awaiting 
transplant has prompted aggressive donor utilization. 
Simultaneously, increasingly moribund and decom-
pensated recipients are undergoing transplantation. 
Thus, early identification and appropriate manage-
ment of poorly functioning grafts have become a criti-
cal aspect of post-transplant care [4,13]. Hepatic artery 
(HAT) or portal venous thrombosis (PVT), and venous 
outflow or biliary obstruction requires timely recogni-
tion and therapy to save or improve liver allograft func-
tion. Similarly, any suspected vascular compromise fol-
lowing renal or pancreatic transplantation necessitates 
swift diagnosis and treatment. Also, modifying, tailor-
ing and balancing immunosuppressive regimen in SOT 
recipients has a pivotal role in combating complications 
inclusive of rejection or infection.
 Is there a need for Transplant Criti-
cal Care?
In 2012, of the total 5,731 adult liver transplants per-
formed in the United States, 17.9% (1,028) occurred 
in recipients with a Model for End-stage Liver Dis-
ease (MELD) score >35 [14]. Before transplantation, 
723 (12.6%) recipients were hospitalized in the ICU 
of which 403 (7%) had been on life support, and 192 
(3.4%) were listed as status 1. Early post-transplant tra-
cheal extubation is safe and suggests efficient resource 
use without significant reduction in ICU or hospital 
length of stay (LOS) in selected liver transplant patients 
[15,16]. However, despite attempts to fast-track care 
and avoid an ICU stay, 45.7% of orthotropic liver trans-
plant (OLT) patients require immediate ICU stay [17].
Infrequent compared to liver, 6.6% (452/6,819) of 
kidney transplant patients demonstrated the need for 
ICU admission in a study by Canet et al. [18]. Forty-
four percent (200) of these patients were admitted for 
acute respiratory failure from bacterial pneumonia 
(35.5%), cardiogenic pulmonary edema (24.5%) and 
extrapulmonary acute respiratory distress syndrome 
(ARDS) (15.5%); and almost half of these patients 
required either, or a combination thereof, mechani-
cal ventilation, vasopressors, and RRT. Other studies 
have shown that up to 20% of renal transplant recipi-
ents require escalation of care from the ward to ICU 
and higher mortality among kidney recipients requir-
ing ICU than the general ICU population (42.6% vs 
30%) [19,20]. Only 1.4% of renal transplant recipients 
are readmitted to the ICU but up to 35% of first time 
successful OLTs return to the ICU primarily for infec-
tious or septic complications (51%), cardiopulmonary 
dysfunction (35%) and graft failure (22%) [21]. Most 
infrequent of the abdominal SOTs, data from 165 ITs 
performed at a single center revealed a mean duration 
of 16+/- 23 ICU days post-transplantation [10]. These 
aforementioned figures underestimate the actual use of 
the ICU by SOT patients because it does not include 
those who get admitted to the ICU with an acute illness 
but recover, those who die in the ICU without having 
their status upgraded, or those who get admitted to the 
ICU for a condition that results in their removal from 
the transplant wait-list [9]. With an increasing number 
of transplant candidates on the list and their extended 
length of time awaiting organs, increasing number of 
patients requiring ICU care before transplantation can 
be anticipated.
Thus, inception of sub-specialized transplant criti-
cal care units at moderate-to-high-volume centers have 
the potential to have a multifold impact - the welfare 
of individual patient(s) and allograft(s), development 
of the multi-organ transplant program, and further the 
understanding of modern surgical critical care of com-
plex SOT patients.
 Patients First, and The Allograft 
Too!
Specialized care is an absolute necessity to combat 
complexities that may occur in transplant candidates 
and recipients. In fact, candidacy for life-saving organs 
relies heavily on the critical management of extremely 
sick patients awaiting transplants. For patients who are 
not transplant candidates, the goal is the restoration of 
pre-ICU functional status, recognizing that ESOF is an 
incurable condition without transplantation [22]. For 
listed transplant patients, the goal is to provide a “win-
dow” of clinical stability when transplantation could be 
feasible. For patients who are possible transplant candi-
dates, the goal is to provide a “window” of opportunity 
to complete a candidacy work-up. The key challenge is 
keeping this “window” open because recurrence of ill-
ness after resolution of the initial episode is common. 
Striving to achieve these “windows” of opportunity 
must be counterbalanced against potentially futile care 
and provision of false hope. In critically ill ESOF pa-
tients, deemed as transplant candidates, the following 
series of events must take place to achieve a good out-
come:
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•	 resolution of acute illness,
•	 non-recurrence of another illness, 
•	 completion of candidacy work-up, and
•	 a successful transplant operation at the availabil-
ity of suitable organ(s).
Provision of post-operative care is a fundamentally 
shared responsibility of the multidisciplinary care team 
including subspecialty physicians, intensivists, and 
transplant surgeons who understand complex anatomy 
as well as the impact of the procedures they perform 
on the individual patient’s physiology [2]. Post-oper-
ative allograft function or dysfunction reflects the in-
terplay of donor factors, the recipient’s acuity and the 
recipient’s operative course [1]. It is not just monitor-
ing of graft function that is vital, but early suspicion 
and recognition of graft dysfunction is critical. While 
implantable continuous Dopplers are being used for 
prompt detection of HAT post-liver transplantation, 
such devices still do not substitute the medical judge-
ment and experience of skilled transplant surgeons in 
conjunction with critical care-trained physicians [10]. 
More importantly, rapid assessment of the recipient 
must be followed up with, if necessary, escalated care 
and definitive therapeutics implemented expeditiously 
sometimes to save an allograft. For example, elevated 
liver function tests (LFTs) post-OLT should prompt 
acquisition and interpretation of liver Doppler images 
with immediate angiographic or operative intervention 
as necessary.
Acute and chronic pathophysiologic changes asso-
ciated with SOT can cause substantial emotional dis-
tress and psychological stresses among this subset of 
patients. These stresses are accentuated in the ICU set-
ting which could influence immediate and long-term 
outcomes of SOT. Thus, in addition to their medical 
needs, it is essential to recognize and address the psy-
chological and psychiatric needs of these patients [23].
 Volume Expansion, Quality Improve-
ment & Resource Utilization
Volume expansion continues to be the biggest chal-
lenge in the field of SOT. Despite significant scientific 
advancements in the process of SOT over the past five 
decades, the stagnant supply of quality organs has been 
unable to match the ongoing demand of allografts. 
In the United States, approximately only a quarter of 
the current wait-listed candidates for all organ types 
(114,561) have been transplanted annually over the 
past decade (27,764 - 34,772) [24]. Thus, to sustain or 
better outcomes one has to think outside the box. 
Three decades ago, up to 40% of all deaths in liver 
transplant recipients occurred in the ICU, mostly from 
infectious causes [25]. Comprehensive understanding 
of SOT physiology and pathophysiology, and advance-
ments in medicine - antibiosis, immunosuppression, 
diagnostic-therapeutic modalities in critical care - have 
effectively reduced the mortality among critically ill 
OLT recipients below the overall mortality rate for all 
ICU admissions (10.6% versus 15%) [21]. Effective 
critical care supports a transplant program’s ability to 
consider high-risk donors and high-risk recipients, 
which expectantly would enhance the overall survival 
of the population of patients with ESOF [1,26]. This is 
where assurance of skillful, experienced, transplant-
specific and critical care competent peri-operative 
management is essential to be able to: 
•	 venture with suboptimal organ offers, 
•	 cater to complex patients with multiple co-mor-
bidities or high “MELDers”, and 
•	 produce consistent and improved results.
Hospitals incur substantial costs due to repetitive, 
redundant and frequently unnecessary physician con-
sultations and diagnostic tests. Also, soaring healthcare 
costs cannot be neglected by the current state of af-
fairs. Care rendered to patients post-transplant (or pre-
transplant) determines their morbidity, mortality and 
largely dictates outcomes, which is perceived as quality. 
Thus, emphasis must be on providing consistent, effi-
cient and high-quality care to patients primarily in a 
high-volume setting to produce and sustain superior 
outcomes.
Undeniably, multidisciplinary care is central to the 
management of SOT patients. Invaluable input from 
experienced specialists in critical care, hepatology, ne-
phrology, anesthesiology, ID, hematology, and pulm-
onology is essential for the successful care of SOT pa-
tients. Patients’ intensive care team also includes, and is 
not limited to, specialized transplant nurses, advanced 
practice providers (APPs), pharmacists, psychologists, 
respiratory-physical-occupational therapists (RT, PT, 
OT), and social workers or case managers. Self-learning 
and continually educating team members is vital. Ad-
ditionally, astute utilization of available resources and 
timely, relevant assistance from interdisciplinary col-
leagues should be the strategy for practical outcomes.
Allotment of physical space with dedicated resources 
solely for a SOT program is a considerable task. Its fea-
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sibility depends on multiple factors including admin-
istrative and financial support based on an institution’s 
individualized funding capabilities, and the influx of 
ESOF patients referred for SOT evaluation. While it 
may be economically justifiable to “concentrate” space 
and resources in establishing a transplant-only ICU 
at high volume multi-organ SOT centers, the concept 
may prove to be inefficient and unjustified with regards 
to apt utilization of resources at low-to-moderate vol-
ume SOT centers. Differently, allocation of designated 
beds within an institution’s existing ICUs (for example, 
5 to 8 beds in a 24-bed medical or surgical ICU) with 
an option to “overflow” may be an equally competent 
alternative. Note, that we emphatically stress the value 
of leading a collaborative, multidisciplinary program 
which includes the aforementioned transplant-special-
ized clinicians and all members of the intensive care 
team. Regardless of the actual existence of a transplant-
only ICU, an ambitious transplant leadership must 
strive to cultivate an intensive care team equipped with 
the “transplant ways” essential to efficiently manage 
ESOF patients, simultaneously and expeditiously en-
able assessment of patients’ candidacy for SOT, and 
treat patients, either peri-operatively or those with 
long-term complications, following SOT. 
While some ESOF patients do not qualify to become 
transplant candidates, some transplant recipients suffer 
and succumb to irreversible graft failure or fatal com-
plications. For these patients, responsibly determining 
futility of care can be a challenge, yet it is essential to 
maintain communication within the multidisciplinary 
care team and with patients or their families to achieve 
early consensus on goals of care for dying transplant 
patients. Timely integration of palliative care alongside 
an aggressive, disease-focused, curative care must be 
accomplished in the ICU to improve the end-of-life 
care practice for patients in whom prolonging treat-
ment is deemed futile [27]. Also, transfer of the termi-
nally ill transplant patient to the ICU must be refrained 
to avoid the unnecessary utilization of resources, the 
provision of false hopes and expectations, and the in-
dignities that occur when suffering and death take 
place in an inappropriate environment [9].
Hence, collaborative efforts between the transplant 
and ICU physicians and teams are essential to the man-
agement of the SOT patient. Creating a workforce of 
clinicians who have training in both specialties may 
help to synergize the care required for this complex pa-
tient population.
 Model Creation, Innovation
The field of SOT has matured significantly over the last 
two decades. Rather than being complacent of the ac-
complishments and accept the status quo, this is the 
time to build, expand and innovate. Advancements 
in operative techniques and developments in immu-
nosuppressive therapy have paved the way to perform 
more complex surgical procedures under challenging 
clinical scenarios. Hence, continually identifying areas 
in need of improvement is essential, and critical trans-
plant care is one such area.
Design and establishment of a goal-directed, dedi-
cated, sub-specialized ICU to cater to the critical needs 
of ESOF patients, either in need of an allograft or those 
who have received one (or more), will provide an op-
portunity to explore novel models in SOT patient care. 
Creation of a prospective database of critically ill trans-
plant candidates and recipients will allow us to:
•	 expand understanding of complex pathologies in 
this unique class of patients, 
•	 assess and improvise day-to-day performance, 
and
•	 modify current protocols and design new ones 
based on evolving evidence.
Such design-thinking makes for a robust approach, 
in combination with creativity, to perform a needs-
finding exercise which can identify unmet needs and 
explore areas of opportunity.
It could be argued that surgeons without formal 
critical care training may not be ideal or rather well-
equipped for managing complicated ventilator settings 
or pressors-ionotropes in hemodynamically labile pa-
tients. However, most abdominal transplant surgeons 
and in-training fellows receive a concentrated experi-
ence in the care of SOT patients including their ICU 
care [2]. That said, this may be an impetus for abdomi-
nal SOT fellowship training programs to expand their 
curriculum involving intensive care. For example, 
“routine” ICU procedures such as endotracheal intu-
bation, advanced ventilator management, fiber op-
tic bronchoscopy and point-of-care-ultrasonography 
(POCUS) should be considered for mandatory inclu-
sions. As surgical training continues to evolve, the in-
clusion of an intensive-care specific curriculum in ad-
dition to the technical training that SOT fellows receive 
may provide a workforce that can straddle the worlds 
of transplant and intensive care. In addition, including 
a transplant-specific rotation during an intensive care 
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fellowship - focusing on the needs of the SOT patient 
without learning the technical aspects - may assist with 
developing the workforce that is necessary for develop-
ing a transplant-specific intensive care model.
 Conclusion
Incorporation of sub-specialized critical care units in 
the management of transplant patients has the poten-
tial to have a global impact. Under a transplant and in-
tensive care physician collaborative leadership model 
synchronized, multidisciplinary and aggressive efforts 
are paramount to:
•	 maximize SOT in qualified potential recipients, 
and
•	 successfully combat probable complications and 
improve overall outcomes in allograft recipients.
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